尼莫地平片，本品为钙拮抗剂，用于缺血性脑血管病、偏头痛、轻度蛛网膜下腔出血所致脑血管痉挛、突发性耳聋、轻、中度高血压。
其中，B、C、D、E厂采用固体分散技术生产的尼莫地平片溶出度均符合部颁标准规定的溶出限度。
The dissolubilities of nimodipine tablets produced by solid dispersed technic from factories B, C, D, E, were in keeping with Chinese WS-(X)-100-2000Z.
结论：尼莫地平分子微囊剂的生物利用度高于尼莫通片。
Conclusion: The bioavailability of nimodipine molecular microcapsule is higher than that of nimodipine tablet.
结论：灰色数学模型可用于描述尼莫地平缓释片的体外释放度。
Conclusion: Gray mathematics model can used for the CARDS that describe the Captopril slow gives releases the slice releases the result outside.
应用推荐